Name: Latest research reports of Windlas Biotech Ltd. authored by Ashika Research and published by - Trendlyne research reports.
Item: Windlas Biotech Ltd.
Rating: 3
Author: Ashika Research

Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329 | ISIN: INE0H5O01029 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1031.3000 -4.90 (-0.47%)

NSE Oct 07, 2026 10:14 AM

47.88% Gain from 52W Low

Volume: 10,366

Windlas Biotech Ltd.

04 Aug 2021

1031.30

-0.47%

Windlas Biotech Ltd. IPO Note

IPO Note: Windlas Biotech Ltd.

Ashika Research

5 each, (Comprising of fresh issue of 3,586,957 Equity Shares* (Rs. 165 cr.) and Offer for Sale of 5,142,067 Equity Shares (Rs. 236.5 cr.*) by Selling Shareholder)....

Number of FII/FPI investors increased from 39 to 48 in Jun 2026 qtr.